| |
|
|
| Address |
39-4,SONGJEONG-RI, BYEONGCHEON-MYEON, CHEONAN-SI, CHUNGNAM |
| Home Page |
www.biolandkorea.com
|
| Established |
1995. 9. 1 |
Tel |
041-564-8615 |
| Listed |
2001. 5.17 |
IR |
041-564-8615 |
| Common shares O/S |
7,500,000 |
President |
Jeong,Chan Bok |
| Preferred shares O/S |
|
No.of Employees |
134(2008. 3) |
| The company posted a steady growth on the back of a 13 billion won investment by SKC. Its profitability remained sound on increased sales and cost management. The company signed a US$3 million deal with an Indian firm to sell its diagnostic reagents kits. |
| Sales are expected to increase steadily on its strengthened business tie-up with SKC and diversified business portfolio. Demand for diagnostic reagents used mainly for PSA and FOB is expected to rise. Its profitability is expected to remain healthy on steady sales growth. |
|
  |
(date: 2007.12, unit : %) |
| Name |
SKC |
Lee Taekseon |
Jeong Chanbok |
| Portion |
14.6 |
12.1 |
8.7 |
|
 |
(unit : %) |
| Sales |
Extract From Crude Drugs |
61.4 |
Cost |
Raw Materials |
|
| Products Of Cultivation Of Micro Organism |
22.9 |
Labors |
|
|
|
Overhead |
|
|
 |
(Unit : 100Mn.Won,Won) |
| Year |
01. 5 |
02. 7 |
07. 9 |
- |
- |
| Type |
LI |
RI |
RI |
- |
- |
| Amount |
23.60 |
8.40 |
5.50 |
- |
- |
|
|
|
|
